metAInsights™ is an AI-powered service for life sciences investors and commercial leads that provides bespoke intelligence on assets and conditions across therapy areas.

Backed by a proprietary agent-based AI system, and built on a dataset of global qualitative market research, metAInsights™ intelligence provides answers to key questions regarding therapy areas and assets across development phases, supporting you in making the correct investment decisions more efficiently.

Curated by experts in their respective fields, our insights are based on interviews with thousands of validated respondents, including patients, HCPs, and payers, and are developed bespoke to answer your specific questions.

metAInsights™ launched in 2024 as part of the Branding Science Group, and our work has already helped industry partners in making better decisions on pharma assets. Please get in touch if you want to learn more about how intelligence from metAInsights™ can help you to make the right investment decisions, faster.”